Harrow Inc - 8.625% NT REDEEM 30/04/2026 USD 25
HROWL
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.59B
Close$
Share Statistics
| Market cap | $1.59 Billion |
|---|---|
| Enterprise Value | $1.80 Billion |
| Dividend Yield | $1.62 (-) |
| Earnings per Share | $-0.14 |
| Beta | 0.14 |
| Outstanding Shares | 37,231,321 |
Return
| Return on Equity | -52.12% |
|---|---|
| Return on Assets | -3.57% |
| Return on Invested Capital | -0.23% |
Valuation & Multiples
| P/E Ratio | -108.89 |
|---|---|
| PEG | -197.12 |
| Price to Sales | 3.66 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 6.7 |
| Enterprise Value to EBIT | -2354.92 |
| Enterprise Value to Net Income | -121 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 10.47 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
March 2, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Harrow Health Inc
125 employeesHarrow Health, Inc. owns a portfolio of ophthalmic pharmaceutical businesses, including ImprimisRx, the nation's leading ophthalmology outsourcing facility and pharmaceutical compounding business. The company holds large equity positions...